23 results
8-K
EX-99.3
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
if it is unable to recruit and enroll a sufficient number of eligible patients to participate in these trials through completion of such trials … investigation;
perceived risks and benefits of the product candidate under study;
Tenet’s ability to recruit clinical trial investigators with the appropriate
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
clinical trials on a timely basis or at all if it is unable to recruit and enroll a sufficient number of eligible patients to participate in these trials … of approved drugs for the disease under investigation;
perceived risks and benefits of the product candidate under study;
Tenet’s ability to recruit
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
not be able to initiate or continue its planned clinical trials on a timely basis or at all if it is unable to recruit and enroll a sufficient number … under study;
Tenet’s ability to recruit clinical trial investigators with the appropriate competencies and experience;
competing clinical trials
10-K
47qqa1sbdj
7 Mar 22
Annual report
4:03pm
10-Q
4gzqktg
13 Sep 21
Quarterly report
4:01pm
424B4
987gsi
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
4ef70
2 Aug 21
IPO registration (amended)
6:08am
S-1
EX-10.2
kuxsk8z
16 Jul 21
IPO registration
5:02pm
S-1
ee2 gif4p8
16 Jul 21
IPO registration
5:02pm